Mallinckrodt Plc, which makes generic opioid painkiller oxycodone, agreed to pay $35 million to settle allegations that it did not report suspicious drug orders, according to a Reuters report. However, Mallinckrodt did not admit any wrongdoing.
The deal was said to be a record settlement resulting from a drug manufacturer not notifying the U.S. Drug Enforcement Administration of suspicious drug orders such as oxycodone, the Justice Department said.
U.S. Attorney General Jeff Sessions said the settlement will send a message to other drugmakers that the Justice Department will hold them accountable for their actions, the story said.
Read the full article